Besifovir dipivoxil maleate

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameBesifovir dipivoxil maleate
Drug Alias Name贝西福韦Besifovir dipivoxil贝司福韦PMCDG dipivoxil贝西福韦酯 +[10] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analoguesSmall molecules > Prodrug
Mechanisms of ActionHBV DNA Polymerase inhibitors
TargetsHBV DNA Polymerase
Therapy Area/IndicationsRenal InsufficiencyHepatitis B, ChronicHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2017/05/15
Country/TerritorySouth KoreaHong Kong
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIldong Pharmaceutical Co Ltd
Inactive CompaniesLg Chemical Ltd
Active IndicationsHepatitis B
Inactive IndicationsRenal InsufficiencyHepatitis B, Chronic

Other Information

ATC CodeJ05AB
Related LinksWikipedia